Evaxion A/S American Depositary Share
Symbol: EVAX (NASDAQ)
2.83
▲ (1.07%) 0.030
Company Description:
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.
Key Stats
- Today's Open: $2.82
- Today's High: $2.915
- Today's Low: $2.73
- Today's Volume: 63.04K
- Yesterday Close: $2.8
- Yesterday High: $3.04
- Yesterday Low: $2.7094
- Yesterday Volume: 64.43K
- Last Min Volume: 10
- Last Min High: $2.83
- Last Min Low: $2.83
- Last Min VWAP: $2.83
Company Profile
- Name: Evaxion A/S American Depositary Share
- Website: https://www.evaxion.ai
- Listed Date: 2021-02-05
- Location: ,
- Market Status: Active
- CIK Number: 0001828253
- SIC Code:
- SIC description:
- Market Cap: $18.63M
- Round Lot: 100
- Outstanding Shares: 6.32M
- Asset Type: ADRC
RECENT FILINGS FOR EVAX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-27 | 6-K | View |
| 2025-08-14 | 6-K | View |
| 2025-08-14 | 6-K | View |
| 2025-08-11 | 6-K | View |
| 2025-07-25 | 6-K | View |
| 2025-07-17 | 6-K | View |
| 2025-07-11 | 6-K | View |
| 2025-07-02 | 6-K | View |
| 2025-06-25 | 6-K | View |
| 2025-06-03 | 6-K | View |
| 2025-05-27 | 6-K | View |
| 2025-05-23 | 6-K | View |
| 2025-05-22 | 6-K | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-05 | 6-K | View |
| 2025-04-29 | 6-K | View |
| 2025-04-28 | 6-K | View |
| 2025-04-10 | 6-K | View |
| 2025-04-07 | 6-K | View |
| 2025-04-01 | 20-F | View |
Latest News on EVAX